Literature DB >> 10581091

Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2.

.   

Abstract

Entities:  

Year:  1999        PMID: 10581091     DOI: 10.1038/71021

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  25 in total

1.  "Pinning strategy": a novel approach for predicting the backbone structure in terms of protein blocks from sequence.

Authors:  A G De Brevern; C Etchebest; C Benros; S Hazout
Journal:  J Biosci       Date:  2007-01       Impact factor: 1.826

Review 2.  Viral vectors: from virology to transgene expression.

Authors:  D Bouard; D Alazard-Dany; F-L Cosset
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

3.  Combined paracrine and endocrine AAV9 mediated expression of hepatocyte growth factor for the treatment of renal fibrosis.

Authors:  Stephanie Schievenbusch; Ingo Strack; Melanie Scheffler; Roswitha Nischt; Oliver Coutelle; Marianna Hösel; Michael Hallek; Jochen W U Fries; Hans-Peter Dienes; Margarete Odenthal; Hildegard Büning
Journal:  Mol Ther       Date:  2010-04-27       Impact factor: 11.454

4.  AAV vectors containing rDNA homology display increased chromosomal integration and transgene persistence.

Authors:  Zhongya Wang; Leszek Lisowski; Milton J Finegold; Hiroyuki Nakai; Mark A Kay; Markus Grompe
Journal:  Mol Ther       Date:  2012-09-18       Impact factor: 11.454

5.  Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism.

Authors:  P Wu; W Xiao; T Conlon; J Hughes; M Agbandje-McKenna; T Ferkol; T Flotte; N Muzyczka
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

6.  Generation and characterization of chimeric recombinant AAV vectors.

Authors:  Bernd Hauck; Ling Chen; Weidong Xiao
Journal:  Mol Ther       Date:  2003-03       Impact factor: 11.454

7.  Durable immunity to oncogenic human papillomaviruses elicited by adjuvanted recombinant Adeno-associated virus-like particle immunogen displaying L2 17-36 epitopes.

Authors:  Subhashini Jagu; Balusubramanyam Karanam; Joshua W Wang; Hatem Zayed; Margit Weghofer; Sarah A Brendle; Karla K Balogh; Kerstin Pino Tossi; Richard B S Roden; Neil D Christensen
Journal:  Vaccine       Date:  2015-09-15       Impact factor: 3.641

8.  Controlling AAV Tropism in the Nervous System with Natural and Engineered Capsids.

Authors:  Michael J Castle; Heikki T Turunen; Luk H Vandenberghe; John H Wolfe
Journal:  Methods Mol Biol       Date:  2016

9.  Characterization of tissue tropism determinants of adeno-associated virus type 1.

Authors:  Bernd Hauck; Weidong Xiao
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

Review 10.  Gene therapy: design and prospects for craniofacial regeneration.

Authors:  E L Scheller; P H Krebsbach
Journal:  J Dent Res       Date:  2009-07       Impact factor: 6.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.